Kavita H Sharma, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 30
- 8 carriers
- Office
- 1
Offices
1 location · South Bay Orthopedic and Sports Medicine Clinic, Inc · 3 clinicians in this group
Plans that list them
30 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sharma’s office at (408) 376-3380 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
30 of 30 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A71740 · Current
Licensed to practise in California · since 2000 · expires 2028-01-31 · Wayne State University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$6,970
Medicare paid this office $6,970 for 41 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 32 | $3,549 | $71 |
Who their Medicare patients are
41 Original Medicare patients in 2024. Average age 75 · Health risk score 0.85. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 59%.
The office billed $30,129, Medicare allowed $10,015 and paid $6,970; for 637 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 41 | 637 | 75 | 0.85 | $30,129 | $6,970 |
| 2023 | 41 | 638 | 73 | 0.79 | $35,076 | $8,528 |
| 2022 | 30 | 66 | 73 | 0.76 | $18,823 | $6,311 |
| 2021 | 51 | 1,149 | 76 | 0.95 | $41,171 | $13,075 |
| 2020 | 59 | 372 | 75 | 0.89 | $58,305 | $14,346 |
| 2019 | 46 | 139 | 74 | 0.84 | $42,807 | $12,095 |
| 2018 | 38 | 159 | 75 | 1.05 | $46,722 | $11,048 |
| 2017 | 35 | 75 | 74 | 0.81 | $24,448 | $5,287 |
| 2016 | 29 | 60 | 70 | 0.97 | $19,128 | $4,515 |
| 2015 | 30 | 60 | 72 | 0.85 | $21,970 | $5,254 |
| 2014 | 26 | 70 | 67 | 0.60 | $24,688 | $5,471 |
| 2013 | 19 | 31 | 68 | 0.70 | $8,782 | $2,703 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Short return visit (20+ min) | 34 | $3,889 | $65 |
2022: 1 service
| Return visit (30+ min) | 17 | $2,716 | $104 |
2021: 3 services
| Return visit (30+ min) | 32 | $4,576 | $104 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 12 | $2,288 | $104 |
| Injection of drug or substance under skin or into muscle | 12 | $383 | $14 |
2020: 5 services
| Return visit (30+ min) | 36 | $5,432 | $89 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 16 | $2,720 | $101 |
| Short return visit (20+ min) | 16 | $1,373 | $62 |
| Injection of drug or substance under skin or into muscle | 19 | $478 | $14 |
| Injection, methylprednisolone acetate, 40 mg | 14 | $82 | None |
2019: 2 services
| Return visit (30+ min) | 26 | $2,571 | $83 |
| Short return visit (20+ min) | 13 | $1,342 | $71 |
2018: 5 services
| Return visit (30+ min) | 22 | $2,523 | $87 |
| Complete ultrasound scan of joint | 14 | $2,361 | $98 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 14 | $1,823 | $91 |
| Short return visit (20+ min) | 16 | $906 | $53 |
| Injection of drug or substance under skin or into muscle | 14 | $387 | $19 |
2017: 1 service
| Return visit (30+ min) | 30 | $2,956 | $76 |
2016: 2 services
| Return visit (30+ min) | 17 | $1,682 | $84 |
| Short return visit (20+ min) | 13 | $1,145 | $60 |
2015: 1 service
| Return visit (30+ min) | 16 | $2,196 | $84 |
2014: 1 service
| Return visit (30+ min) | 19 | $3,257 | $81 |
2013: 1 service
| Return visit (30+ min) | 13 | $1,830 | $91 |
Drugs they prescribed that Part D paid
$49,769
Pharmacies billed $49,769 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
920 generic and fewer than 11 brand-name prescriptions · $49,769 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Levothyroxine | 72 | $906 | $13 |
| Atorvastatin | 91 | $846 | $9 |
| Albuterol Sulfate Hfa | 30 | $740 | $25 |
| Amlodipine Besylate | 66 | $612 | $9 |
| Duloxetine | 13 | $595 | $46 |
See all 25 drugs
| Levothyroxine | 72 | $906 | $13 |
| Atorvastatin | 91 | $846 | $9 |
| Albuterol Sulfate Hfa | 30 | $740 | $25 |
| Amlodipine Besylate | 66 | $612 | $9 |
| Duloxetine | 13 | $595 | $46 |
| Celecoxib | 15 | $356 | $24 |
| Metoprolol | 30 | $336 | $11 |
| Famotidine | 22 | $315 | $14 |
| Simvastatin | 29 | $272 | $9 |
| Rosuvastatin | 20 | $259 | $13 |
| Losartan | 33 | $242 | $7 |
| Lisinopril | 30 | $231 | $8 |
| Metformin | 37 | $230 | $6 |
| Omeprazole | 22 | $213 | $10 |
| Allopurinol | 16 | $156 | $10 |
| Carvedilol | 13 | $155 | $12 |
| Alendronate | 35 | $155 | $4 |
| Trazodone | 23 | $154 | $7 |
| Furosemide | 13 | $150 | $12 |
| Losartan-Hydrochlorothiazide | 11 | $131 | $12 |
| Wixela Inhub | 12 | $95 | $8 |
| Metformin Hcl Er | 11 | $81 | $7 |
| Atenolol | 23 | $65 | $3 |
| Hydrochlorothiazide | 25 | $41 | $2 |
| Meloxicam | 11 | $4 | $0 |
Year by year
| 2024 | 1,016 | 112 | None | None | $49,769 |
| 2023 | 1,241 | 141 | 1% (15) | 12% | $96,841 |
| 2022 | 1,231 | 139 | 1% (11) | 14% | $93,139 |
| 2021 | 1,027 | 135 | 2% (24) | None | $70,862 |
| 2020 | 728 | 114 | 2% (12) | 16% | $44,912 |
| 2019 | 676 | 98 | 2% (13) | None | $36,421 |
| 2018 | 556 | 81 | 3% (18) | None | $26,208 |
| 2017 | 523 | 81 | 5% (24) | None | $23,947 |
| 2016 | 312 | 59 | 7% (23) | None | $12,998 |
| 2015 | 427 | 60 | 6% (24) | 19% | $11,258 |
| 2014 | 425 | 46 | 9% (37) | None | $13,697 |
| 2013 | 357 | 51 | 9% (33) | None | $12,792 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 29 drugs
| Eliquis | 15 | $9,944 | $663 |
| Wixela Inhub | 12 | $1,957 | $163 |
| Atorvastatin | 85 | $1,653 | $19 |
| Levothyroxine | 82 | $1,511 | $18 |
| Amlodipine Besylate | 81 | $1,093 | $13 |
| Metformin | 46 | $683 | $15 |
| Metoprolol | 31 | $660 | $21 |
| Albuterol Sulfate Hfa | 18 | $632 | $35 |
| Losartan-Hydrochlorothiazide | 21 | $552 | $26 |
| Gabapentin | 24 | $510 | $21 |
| Lisinopril | 40 | $469 | $12 |
| Omeprazole | 26 | $459 | $18 |
| Famotidine | 16 | $425 | $27 |
| Losartan | 34 | $425 | $13 |
| Allopurinol | 24 | $420 | $17 |
| Carvedilol | 23 | $378 | $16 |
| Tamsulosin | 14 | $360 | $26 |
| Simvastatin | 32 | $338 | $11 |
| Rosuvastatin | 23 | $305 | $13 |
| Finasteride | 15 | $293 | $20 |
| Alendronate | 30 | $275 | $9 |
| Atenolol | 28 | $240 | $9 |
| Furosemide | 28 | $199 | $7 |
| Montelukast | 14 | $183 | $13 |
| Venlafaxine Hcl Er | 11 | $168 | $15 |
| Metformin Hcl Er | 12 | $136 | $11 |
| Trazodone | 15 | $115 | $8 |
| Ibuprofen | 14 | $105 | $8 |
| Hydrochlorothiazide | 19 | $53 | $3 |
2022: 32 drugs
| Eliquis | 21 | $12,830 | $611 |
| Tresiba Flextouch U-100 | 11 | $11,702 | $1,064 |
| Levothyroxine | 102 | $1,871 | $18 |
| Atorvastatin | 102 | $1,569 | $15 |
| Metoprolol | 31 | $693 | $22 |
| Metformin | 52 | $646 | $12 |
| Amlodipine Besylate | 69 | $611 | $9 |
| Albuterol Sulfate Hfa | 12 | $602 | $50 |
| Simvastatin | 45 | $575 | $13 |
| Chlorthalidone | 13 | $539 | $41 |
| Famotidine | 22 | $496 | $23 |
| Lisinopril | 33 | $403 | $12 |
| Rosuvastatin | 18 | $376 | $21 |
| Carvedilol | 19 | $349 | $18 |
| Omeprazole | 22 | $297 | $13 |
| Losartan-Hydrochlorothiazide | 12 | $285 | $24 |
| Trazodone | 17 | $275 | $16 |
| Allopurinol | 13 | $252 | $19 |
| Diclofenac | 11 | $249 | $23 |
| Alendronate | 25 | $235 | $9 |
| Furosemide | 24 | $215 | $9 |
| Gabapentin | 20 | $187 | $9 |
| Triamterene-Hydrochlorothiazid | 12 | $158 | $13 |
| Ibuprofen | 25 | $143 | $6 |
| Atenolol | 29 | $140 | $5 |
| Fluticasone Propionate | 11 | $130 | $12 |
| Losartan | 15 | $107 | $7 |
| Hydrochlorothiazide | 22 | $105 | $5 |
| Ketoconazole | 17 | $67 | $4 |
| Metformin Hcl Er | 13 | $51 | $4 |
| Metoprolol | 11 | $47 | $4 |
| Meloxicam | 17 | $37 | $2 |
2021: 24 drugs
| Levothyroxine | 80 | $1,778 | $22 |
| Atorvastatin | 81 | $1,312 | $16 |
| Celecoxib | 23 | $999 | $43 |
| Metoprolol | 31 | $701 | $23 |
| Lisinopril | 30 | $513 | $17 |
| Diclofenac | 20 | $495 | $25 |
| Amlodipine Besylate | 55 | $469 | $9 |
| Allopurinol | 15 | $381 | $25 |
| Simvastatin | 39 | $350 | $9 |
| Trazodone | 13 | $306 | $24 |
| Metformin | 31 | $305 | $10 |
| Chlorthalidone | 11 | $304 | $28 |
| Ibuprofen | 39 | $299 | $8 |
| Gabapentin | 25 | $285 | $11 |
| Spironolactone | 11 | $220 | $20 |
| Triamterene-Hydrochlorothiazid | 18 | $216 | $12 |
| Alendronate | 16 | $207 | $13 |
| Omeprazole | 20 | $186 | $9 |
| Furosemide | 19 | $178 | $9 |
| Hydrocodone-Acetaminophen | 15 | $174 | $12 |
| Losartan | 12 | $159 | $13 |
| Hydrochlorothiazide | 31 | $97 | $3 |
| Sulfamethoxazole-Trimethoprim | 11 | $59 | $5 |
| Meloxicam | 26 | $48 | $2 |
2020: 15 drugs
| Levothyroxine | 79 | $1,961 | $25 |
| Atorvastatin | 47 | $817 | $17 |
| Metoprolol | 14 | $801 | $57 |
| Celecoxib | 21 | $490 | $23 |
| Trazodone | 16 | $373 | $23 |
| Lisinopril | 25 | $292 | $12 |
| Amlodipine Besylate | 37 | $264 | $7 |
| Ibuprofen | 30 | $244 | $8 |
| Simvastatin | 32 | $195 | $6 |
| Allopurinol | 14 | $189 | $14 |
| Losartan | 14 | $164 | $12 |
| Metformin | 18 | $145 | $8 |
| Gabapentin | 28 | $142 | $5 |
| Hydrochlorothiazide | 16 | $93 | $6 |
| Latanoprost | 11 | $56 | $5 |
2019: 22 drugs
| Januvia | 16 | $9,059 | $566 |
| Levothyroxine | 68 | $1,764 | $26 |
| Trazodone | 26 | $1,014 | $39 |
| Metoprolol | 17 | $997 | $59 |
| Rosuvastatin | 15 | $710 | $47 |
| Atenolol-Chlorthalidone | 12 | $440 | $37 |
| Atorvastatin | 26 | $407 | $16 |
| Losartan | 20 | $345 | $17 |
| Duloxetine | 12 | $315 | $26 |
| Simvastatin | 31 | $277 | $9 |
| Ibuprofen | 22 | $271 | $12 |
| Amlodipine Besylate | 33 | $230 | $7 |
| Allopurinol | 15 | $218 | $15 |
| Lisinopril | 16 | $217 | $14 |
| Gabapentin | 24 | $205 | $9 |
| Metformin | 19 | $158 | $8 |
| Sertraline | 16 | $143 | $9 |
| Alendronate | 18 | $135 | $8 |
| Hydrochlorothiazide | 12 | $90 | $7 |
| Hydrocodone-Acetaminophen | 11 | $78 | $7 |
| Meloxicam | 16 | $78 | $5 |
| Glipizide | 16 | $39 | $2 |
2018: 14 drugs
| Levothyroxine | 61 | $1,381 | $23 |
| Rosuvastatin | 24 | $899 | $37 |
| Trazodone | 14 | $607 | $43 |
| Atorvastatin | 21 | $445 | $21 |
| Metoprolol | 11 | $335 | $30 |
| Simvastatin | 21 | $255 | $12 |
| Losartan | 17 | $237 | $14 |
| Lisinopril | 26 | $234 | $9 |
| Amlodipine Besylate | 22 | $145 | $7 |
| Alendronate | 21 | $131 | $6 |
| Metoprolol | 13 | $129 | $10 |
| Meloxicam | 25 | $103 | $4 |
| Gabapentin | 14 | $94 | $7 |
| Hydrochlorothiazide | 13 | $64 | $5 |
2017: 18 drugs
| Levothyroxine | 39 | $998 | $26 |
| Celecoxib | 13 | $947 | $73 |
| Synthroid | 16 | $560 | $35 |
| Atorvastatin | 32 | $401 | $13 |
| Hydrocodone-Acetaminophen | 21 | $215 | $10 |
| Triamterene-Hydrochlorothiazid | 13 | $189 | $15 |
| Omeprazole | 14 | $156 | $11 |
| Losartan | 23 | $152 | $7 |
| Metoprolol | 21 | $144 | $7 |
| Amlodipine Besylate | 23 | $133 | $6 |
| Lisinopril | 21 | $123 | $6 |
| Simvastatin | 12 | $122 | $10 |
| Ibu | 15 | $121 | $8 |
| Fluticasone Propionate | 11 | $115 | $10 |
| Ibuprofen | 13 | $100 | $8 |
| Hydrochlorothiazide | 12 | $98 | $8 |
| Alendronate | 13 | $56 | $4 |
| Meloxicam | 13 | $44 | $3 |
2016: 10 drugs
| Dilantin | 12 | $1,209 | $101 |
| Synthroid | 21 | $871 | $41 |
| Levothyroxine | 25 | $648 | $26 |
| Hydrocodone-Acetaminophen | 22 | $503 | $23 |
| Duloxetine | 16 | $202 | $13 |
| Atorvastatin | 14 | $174 | $12 |
| Metoprolol | 15 | $122 | $8 |
| Lisinopril | 11 | $90 | $8 |
| Losartan | 13 | $79 | $6 |
| Meloxicam | 12 | $68 | $6 |
2015: 18 drugs
| Dilantin | 13 | $1,020 | $78 |
| Voltaren | 18 | $920 | $51 |
| Synthroid | 21 | $696 | $33 |
| Levothyroxine | 37 | $575 | $16 |
| Hydrocodone-Acetaminophen | 18 | $408 | $23 |
| Atorvastatin | 30 | $330 | $11 |
| Metoprolol | 12 | $265 | $22 |
| Simvastatin | 20 | $232 | $12 |
| Venlafaxine Hcl Er | 12 | $139 | $12 |
| Ibuprofen | 16 | $121 | $8 |
| Trazodone | 18 | $106 | $6 |
| Omeprazole | 11 | $98 | $9 |
| Warfarin | 13 | $94 | $7 |
| Lisinopril | 22 | $82 | $4 |
| Metformin | 13 | $63 | $5 |
| Hydrochlorothiazide | 11 | $49 | $4 |
| Clonidine | 12 | $47 | $4 |
| Glipizide | 11 | $46 | $4 |
2014: 16 drugs
| Androderm | 11 | $2,688 | $244 |
| Proair Hfa | 14 | $1,459 | $104 |
| Synthroid | 24 | $738 | $31 |
| Hydrocodone-Acetaminophen | 21 | $436 | $21 |
| Levothyroxine | 32 | $401 | $13 |
| Atorvastatin | 29 | $324 | $11 |
| Pantoprazole | 12 | $324 | $27 |
| Lisinopril | 20 | $171 | $9 |
| Simvastatin | 23 | $168 | $7 |
| Trazodone | 17 | $150 | $9 |
| Hydrochlorothiazide | 18 | $113 | $6 |
| Tramadol | 11 | $107 | $10 |
| Ibuprofen | 13 | $95 | $7 |
| Clonidine | 12 | $68 | $6 |
| Alprazolam | 11 | $58 | $5 |
| Furosemide | 11 | $33 | $3 |
2013: 12 drugs
| Nexium | 12 | $2,225 | $185 |
| Dilantin | 12 | $774 | $64 |
| Hydrocodone-Acetaminophen | 27 | $372 | $14 |
| Synthroid | 13 | $331 | $25 |
| Metolazone | 11 | $269 | $24 |
| Atorvastatin | 13 | $247 | $19 |
| Simvastatin | 30 | $245 | $8 |
| Levothyroxine | 29 | $235 | $8 |
| Lisinopril | 18 | $121 | $7 |
| Hydrochlorothiazide | 16 | $113 | $7 |
| Atenolol | 15 | $68 | $5 |
| Furosemide | 12 | $43 | $4 |
Money from drug and device companies
$48 in 2025
| 2025 | 2 | 2 | None | $48 |
| 2019 | 1 | 1 | None | $19 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Smith+Nephew | Bioinductive Implant With Arthroscopic Delivery System - Medium | $31 | 1 payment
|
| Bioventus | Xcell | $17 | 1 payment
|
See all 2 published payments
| Bioventus | Meals · 2025-09-03 | Xcell | $17 |
| Smith+Nephew | Meals · 2025-04-24 | Bioinductive Implant With Arthroscopic Delivery System - Medium | $31 |
See earlier years (2019)
2019: $19
| Bioventus | Durolane | $19 | 1 payment
|
Professional record
- NPI
- 1952401960
- Licence
- CA A71740California A71740: Current · expires 2028-01-31
- Trained
- Wayne State University School of Medicine, 1991
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 2386 Bentley Ridge Dr, San Jose, CA, 95138
- NPI first listed
- 2006-09-22
- NPI last updated
- 2022-12-13
- NPI record certified
- 2022-12-13
This is when the NPI record was last certified, not a medical board exam.